The Healthcare News Diaries
FTC sues big pharmacy advantage supervisors about insulin prices The agency brought action in opposition to Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the list price of life-saving insulin drugs.Elevance lowers guidance on ‘unprecedented’ Medicaid chal